1,125
Participants
Start Date
September 4, 2023
Primary Completion Date
May 29, 2025
Study Completion Date
May 29, 2025
Entresto
There is no treatment allocation. Patients administered Entresto by prescription that have started before inclusion of the patient into the study will be enrolled.
Novartis Investigative Site, Machida
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Saitama
Novartis Investigative Site, Asaka
Novartis Investigative Site, Anjo
Novartis Investigative Site, Ichinomiya
Novartis Investigative Site, Kasugai
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Okazaki
Novartis Investigative Site, Ōbu
Novartis Investigative Site, Toyohashi
Novartis Investigative Site, Yatomi
Novartis Investigative Site, Inzai
Novartis Investigative Site, Matsudo
Novartis Investigative Site, Sakura
Novartis Investigative Site, Yotsukaidō
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Saijō
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Kasuga
Novartis Investigative Site, Kasuga
Novartis Investigative Site, Kasuya Gun
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Kurume
Novartis Investigative Site, Nakagawa
Novartis Investigative Site, Omuta
Novartis Investigative Site, Yame
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Takehara
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Akashi
Novartis Investigative Site, Amagasaki
Novartis Investigative Site, Kasai
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Nishinomiya
Novartis Investigative Site, Bandō
Novartis Investigative Site, Chikusei
Novartis Investigative Site, Koga
Novartis Investigative Site, Moriya
Novartis Investigative Site, Ryūgasaki
Novartis Investigative Site, Kanazawa
Novartis Investigative Site, Kagoshima
Novartis Investigative Site, Aiko-gun
Novartis Investigative Site, Fujisawa
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokosuka
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Yamaga
Novartis Investigative Site, Iki
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Nakatsu
Novartis Investigative Site, Ōita
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Hirakata
Novartis Investigative Site, Ikeda
Novartis Investigative Site, Minoo
Novartis Investigative Site, Moriguchi
Novartis Investigative Site, Moriguchi
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Suita
Novartis Investigative Site, Suita
Novartis Investigative Site, Takatsuki
Novartis Investigative Site, Toyonaka
Novartis Investigative Site, Kashima
Novartis Investigative Site, Kishima-gun
Novartis Investigative Site, Tosu
Novartis Investigative Site, Ureshino
Novartis Investigative Site, Fujimino
Novartis Investigative Site, Gyōda
Novartis Investigative Site, Kawaguchi
Novartis Investigative Site, Niiza
Novartis Investigative Site, Saitama
Novartis Investigative Site, Satte
Novartis Investigative Site, Sayama
Novartis Investigative Site, Tokorozawa
Novartis Investigative Site, Tokorozawa
Novartis Investigative Site, Akishima
Novartis Investigative Site, Edogawa-ku
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Katsushika-ku
Novartis Investigative Site, Kokubunji
Novartis Investigative Site, Koto-ku
Novartis Investigative Site, Machida
Novartis Investigative Site, Machida
Novartis Investigative Site, Mitaka
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Setagaya-ku
Novartis Investigative Site, Shibuya City
Novartis Investigative Site, Toshima-ku
Novartis Investigative Site, Takaoka
Novartis Investigative Site, Shimonoseki
Novartis Investigative Site, Yamaguchi
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Saitama
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY